To manufacture an implantable medical device in India, a company must obtain the CDSCO MD9 manufacturing license (applied via Form MD7 on the SUGAM portal). Implantable devices are classified as Class C or Class D medical devices under the Medical Devices Rules, 2017, because they remain inside the body — often permanently — in direct contact with tissue, organs, or vital systems, and any failure carries serious clinical risk. The MD9 and MD15 licenses are granted by the Central Licensing Authority (CDSCO Headquarters) and remain valid indefinitely, subject to a retention fee every 5 years. A loan license (MD10, Form MD8) is available for manufacturers without their own facility, and an MD15 import license (Form MD14) is required to import implants into India.
Implantable medical devices occupy the highest-stakes corner of India's medical device landscape. Once placed in a patient — whether a spinal cage, a breast implant, a cardiac stent, or a pacemaker — these devices are designed to remain in the body for an extended period, sometimes for life, sitting in continuous contact with internal tissue, organs, and bodily fluids. There is no "minor" failure mode for a device in this category: a defect that would be a quality complaint for a surface device becomes a revision surgery for an implant. CDSCO's regulatory framework reflects that reality, and no company should approach implant manufacturing or import without first understanding the licensing pathway in detail.
This guide provides everything you need to understand the CDSCO licensing pathway for implantable medical devices in India — from classification and license type through to the documents CDSCO reviewers scrutinise most carefully and the steps that lead to a successful application on first submission.
📑 Quick Navigation
- Why Implantable Devices Sit at the Top of CDSCO's Risk Pyramid
- CDSCO Device Classification for Implantable Medical Devices
- Which CDSCO License Does an Implantable Device Manufacturer or Importer Need?
- Complete Document Checklist for the CDSCO Implantable Device License
- 11-Step SUGAM Application Process
- License Validity and Post-Grant Obligations
- Common Errors That Delay Implantable Device License Applications
- Frequently Asked Questions
Why Implantable Devices Sit at the Top of CDSCO's Risk Pyramid
An implantable medical device is one that is introduced — surgically or medically — partly or wholly into the human body and is intended to remain there after the procedure. That single design characteristic changes everything about how the device must be regulated. A device that lives outside the body can be removed, replaced, or recalled with comparatively low clinical disruption. A device that lives inside the body, often permanently, cannot be addressed without a further surgical intervention, and every additional surgery carries its own risk of infection, complications, and recovery burden for the patient.
Because implants operate in constant contact with internal tissue and bodily fluids — sometimes for the patient's entire lifetime — even a small manufacturing defect, a material that degrades faster than expected, or a biological rejection response can become a life-threatening event. Correcting that event almost always means invasive revision surgery, which compounds the original risk. CDSCO's response to this risk profile is to place implantable devices under the highest classification tiers and to require centralised review, comprehensive technical documentation, and facility auditing before any such device can be manufactured or imported for the Indian market.
CDSCO Device Classification for Implantable Medical Devices
Under the Medical Devices Rules, 2017, CDSCO classifies medical devices into four risk classes — A, B, C, and D — based on the level of risk the device poses to the patient or user. The classification of your specific product determines which license pathway applies, which authority grants the license, and the depth of technical and clinical documentation required.
| Device Type | Typical CDSCO Class | Risk Level | License Required | Licensing Authority |
|---|---|---|---|---|
| Orthopaedic implants (bone plates, screws) | Class C | Moderate-High | MD9 (Form MD7) | Central Licensing Authority |
| Breast implants, spinal cages | Class C | Moderate-High | MD9 (Form MD7) | Central Licensing Authority |
| Cardiac stents, heart valves | Class D | High | MD9 (Form MD7) | Central Licensing Authority |
| Pacemakers, implantable cardioverter-defibrillators | Class D | High | MD9 (Form MD7) | Central Licensing Authority |
Which CDSCO License Does an Implantable Device Manufacturer or Importer Need?
For Class C and Class D implantable devices, CDSCO provides distinct pathways depending on whether the applicant intends to manufacture in India with their own facility, manufacture through a third party, or import a finished device manufactured abroad.
MD9 Manufacturing License
- Application form: Form MD7 on SUGAM
- License granted as: MD9
- Granted by: Central Licensing Authority (CDSCO HQ)
- Requirement: Applicant owns or controls a GMP-compliant manufacturing facility
- Validity: Indefinite, 5-year retention fee
- Best for: Companies manufacturing implants at their own facility in India
MD10 Loan License
- Application form: Form MD8 on SUGAM
- License granted as: MD10
- Granted by: Central Licensing Authority (CDSCO HQ)
- Requirement: Access to the manufacturing facility of a company already producing the same category of implant
- Validity: Indefinite, 5-year retention fee
- Best for: Companies without their own implant manufacturing infrastructure
CDSCO MD9 Manufacturing License in 2026: Procedure & Documents
A closer look at the MD9 licensing process for Class C and Class D medical devices — Form MD7, the Central Licensing Authority pathway, the document set, and how CDSCO audits high-risk manufacturing facilities.
Complete Document Checklist for the CDSCO Implantable Device License
The document requirements for an implantable device license are more extensive than for lower-risk Class A or B devices, reflecting the heightened scrutiny CDSCO applies to devices that remain inside the body. Every document in this list must be present, accurate, and consistent with your facility and product before submission. Incomplete or internally inconsistent document sets are the leading cause of application queries and audit observations for implant applications.
- Cover letter — Addressed to CDSCO, referencing the applicable form (MD7, MD8, or MD14) and identifying the product, its classification, and the applicant's details.
- Organisation identity proof — Memorandum of Association, list of directors or partners, UDYAM Aadhar, or PAN card establishing the identity of the applicant entity.
- Facility ownership or occupancy proof — Sale deed or registered lease/rent agreement confirming the applicant's legal right to occupy the manufacturing premises.
- Dimensioned facility layout — A detailed, scaled drawing of the manufacturing facility showing the dimensions of each room and the location of all equipment.
- ISO 13485 Certificate — Current, valid ISO 13485 certificate for the quality management system at the manufacturing facility.
- Plant Master File (PMF) — The facility document describing infrastructure, layout, equipment, quality management system, personnel, and GMP compliance measures.
- Device Master File (DMF) — The technical dossier covering the implant's design, materials, manufacturing process, testing procedures, validation data, and risk analysis under ISO 14971.
- Environmental compliance documents — Records demonstrating compliance with applicable environmental requirements for the manufacturing facility.
- Test license (if applicable) — Required if the applicant is yet to commence commercial manufacturing and needs to produce test batches for the purpose of the license application.
- Technical staff qualification records — Details and qualifications of the personnel responsible for manufacturing and testing the implantable device.
- Free sale certificate — Required for MD15 import license applications, confirming the device is freely sold in the country of origin or another reference market.
- Certificate of analysis — Laboratory analysis demonstrating that the device meets the required quality and performance standards.
11-Step SUGAM Application Process for the CDSCO Implantable Device License
All CDSCO medical device license applications are submitted through the SUGAM online portal at cdscoonline.gov.in. Because implantable devices are reviewed centrally and typically require a facility audit, the process for Class C and Class D implants involves eleven structured steps from portal login to license grant.
Navigate to cdscoonline.gov.in and sign in to your existing account, or register a new account for your company. Ensure the account is registered under the correct legal entity — the same entity that will hold the manufacturing or import license. Account-level errors discovered after submission cause significant delays for high-value implant applications.
Before selecting an application form, verify whether your implant is correctly classified as Class C or Class D under MDR 2017. Given the clinical stakes, an incorrect classification at this stage can result in the application being routed to the wrong authority or rejected outright. Consult a regulatory affairs specialist if your device's classification is not immediately clear from CDSCO's classification guidance.
Fill in Form MD7 for a manufacturing license (MD9), Form MD8 for a loan license (MD10), or Form MD14 for an import license (MD15). This requires the device's official brand name, intended use statement (which must match the Device Master File exactly), CDSCO classification, a detailed product description including materials and design, and complete details of the manufacturing facility or, for imports, the foreign manufacturing site and Indian Authorised Agent.
Upload each document from the checklist above in the format and file size specified by SUGAM. The Device Master File and Plant Master File must be complete, internally consistent, and reviewed by your QA and regulatory teams before upload — for Class C and D devices, these documents are read in far greater depth than for lower-risk categories, and any gaps tend to surface as queries or audit observations.
Pay the applicable license application fee through the SUGAM portal. The fee is determined by the device's risk class and the type of application (manufacturing, loan, or import). Retain proof of payment, as fee payment triggers the official submission record in CDSCO's system and starts the review timeline.
Upon successful submission and fee payment, SUGAM issues an application reference number. This number is your record of submission and is required for all correspondence with CDSCO about the application's status. Save it immediately and retain it throughout the review process, which for implantable devices can extend over several months.
CDSCO Headquarters carries out a detailed review of the application and all uploaded documents. For Class C and Class D devices, this includes a thorough technical assessment of the Device Master File — covering design, materials, biocompatibility, and performance testing — alongside a review of the Plant Master File to confirm the facility is capable of producing implant-grade devices under GMP conditions.
If CDSCO raises queries — requests for clarification of technical claims, additional test data, or supplementary documentation — respond promptly and thoroughly through the SUGAM portal within the timeframe specified. Given the technical depth of implant dossiers, queries at this stage are common; assign a named regulatory lead to coordinate accurate, complete responses.
CDSCO officials conduct an on-site audit of the manufacturing facility to verify regulatory compliance. For implantable devices, auditors examine the facility against the Plant Master File in detail — clean room conditions, equipment qualification, material traceability, personnel competence, and quality system records are all assessed against what was declared in the application.
CDSCO reviews the audit report together with the application documents and any justifications or corrective actions submitted by the applicant in response to audit observations. If the facility, documentation, and justifications align with regulatory requirements, the application proceeds toward grant.
Once all documentation, query responses, and audit requirements are satisfied, CDSCO grants the applicable license — MD9 for manufacturing, MD10 for loan licensing, or MD15 for import. The license is issued on SUGAM and specifies the product, the manufacturing or import site, and the license holder. Review the license details carefully and flag any errors to CDSCO immediately for correction.
License Validity and Post-Grant Obligations
The CDSCO license for an implantable medical device — whether MD9, MD10, or MD15 — is granted with indefinite validity. There is no mandatory renewal period, which is a significant structural feature of the Indian medical device licensing framework.
Beyond the retention fee, license holders for implantable devices carry ongoing obligations that apply throughout the license period — and these are taken particularly seriously for devices that remain in patients' bodies long after the point of sale:
- Maintain the Plant Master File as a living document — Any material change to the manufacturing facility, materials, or process requires the PMF and DMF to be updated through change control before the next regulatory interaction.
- Adverse event and field safety reporting — Any serious adverse events, device failures, or field safety actions associated with the implant must be reported to CDSCO through SUGAM within the timelines specified under MDR 2017.
- Complaint handling and CAPA — An operational complaint handling system and corrective and preventive action (CAPA) process must be maintained and documented throughout the license period, with particular attention to long-term implant performance data.
- GMP compliance and surveillance — The manufacturing facility must maintain continuous GMP compliance. CDSCO may conduct surveillance inspections without prior notice during the license period, particularly for Class D devices.
- License variation for significant changes — Changes to the implant's design, materials, manufacturing process, or facility that are material to the licensed product require a license variation application before implementation.
How to Prepare the CDSCO Device Master File in 2026 — Complete Guide
The Device Master File is the single most scrutinised document in an implantable device application. This guide covers the technical sections CDSCO reviewers focus on, how to structure biocompatibility and performance data, and how the DMF is used during facility audits.
Common Errors That Delay Implantable Device License Applications
| Error Type | What Goes Wrong | How to Prevent It |
|---|---|---|
| Wrong classification or pathway applied | Applicant assumes a Class B pathway, or chooses MD9 when an MD15 import application was required | Confirm classification and license pathway with a regulatory consultant before submission; verify the correct form (MD7, MD8, or MD14) for the situation |
| Intended use mismatch | The intended use statement in the application form does not match the DMF's intended use — triggers an immediate query | Cross-check the application form against the DMF before submission; use identical wording throughout |
| Incomplete Device Master File | DMF missing biocompatibility data, risk management file, or validation reports for implant-specific materials | Use a structured DMF checklist tailored to Class C/D implants and have QA and clinical/regulatory teams review the DMF before upload |
| Plant Master File not reflecting actual facility | PMF describes equipment, clean room classifications, or processes that do not match the physical facility — detected at audit | Conduct a pre-submission facility walk-through, checking every PMF claim against physical reality before the audit team arrives |
| Expired ISO 13485 certificate | Certificate submitted is within months of expiry or has already expired — flagged as a quality system concern for a high-risk device | Check certificate expiry well before submission; renew with sufficient buffer given the extended review timelines for implants |
| Missing free sale certificate (import applications) | MD15 application submitted without a valid free sale certificate from the country of origin or a reference market | Obtain and authenticate the free sale certificate early, as it can take time to procure from the originating regulatory authority |
| Facility layout not dimensioned | Floor plan submitted lacks room dimensions or equipment positions, and does not match what auditors observe on-site | Engage a professional draftsperson; confirm layout drawings are scaled, dimensioned, labelled, and current before inclusion |
Frequently Asked Questions
Is an implantable medical device a regulated medical device in India?
Yes. Implantable devices — including orthopaedic implants, breast implants, spinal cages, cardiac stents, heart valves, pacemakers, and implantable cardioverter-defibrillators — are regulated as Class C or Class D medical devices under the Medical Devices Rules, 2017 (MDR 2017). Manufacturers and importers must hold a valid CDSCO license (MD9, MD10, or MD15 as applicable) before such devices are manufactured, sold, imported, or distributed in India. Dealing in unregistered implantable devices is an offence under MDR 2017 and the Drugs and Cosmetics Act.
How long does it take to get a CDSCO implantable device license?
The timeline depends heavily on the completeness and technical quality of the application, and on the facility audit process required for Class C and Class D devices. For a well-prepared, query-free application that clears the audit without major observations, the license is typically granted over several months from submission. Applications that generate technical queries or significant audit observations can take considerably longer. Engaging a regulatory consultant experienced with implant dossiers can substantially reduce delays by ensuring the Device Master File and Plant Master File are audit-ready from the outset.
Can a foreign company apply for a CDSCO MD9 manufacturing license?
No. The MD9 manufacturing license is granted only to entities with a manufacturing facility physically located in India and licensed under Indian law. Foreign manufacturers that produce implantable devices outside India and wish to sell them in India must instead obtain the MD15 import license (Form MD14) and appoint an Indian Authorised Agent as their regulatory representative. The licensing requirements for domestic manufacturing and import are separate, though the underlying technical documentation overlaps significantly.
Does CDSCO require ISO 13485 certification for an implantable device license?
Yes. A valid ISO 13485 certificate for the quality management system at the manufacturing facility is a mandatory document for MD9, MD10, and MD15 applications. Given the elevated risk associated with implantable devices, the certificate's scope must clearly cover the manufacturing activities relevant to the implant, and it must remain valid throughout the (often lengthy) review and audit process.
What happens if I manufacture or import implantable devices without a CDSCO license?
Manufacturing, importing, selling, or distributing implantable medical devices without the required CDSCO license is an offence under the Drugs and Cosmetics Act, 1940, as amended, and under MDR 2017. Given that these devices are placed inside patients, penalties for non-compliance are applied strictly and can include product seizure, facility or import suspension, substantial fines, and potential criminal liability for responsible persons within the company.
✓ Key Takeaways
- Implantable medical devices are classified as Class C or Class D under MDR 2017 — an MD9 manufacturing license (Form MD7) or MD15 import license (Form MD14) is mandatory before any such device is manufactured, sold, or imported in India
- The MD9, MD10, and MD15 licenses are granted by the Central Licensing Authority (CDSCO Headquarters), not the State Licensing Authority
- Companies without their own facility can obtain a loan license (MD10, Form MD8) to manufacture through another company's compliant facility
- Foreign manufacturers must use the MD15 import pathway via an Indian Authorised Agent — the MD9 route is for domestic manufacturing only
- The Device Master File and Plant Master File receive the deepest technical scrutiny of any CDSCO application category, and must be audit-ready, not just submission-ready
- A facility audit and inspection by CDSCO is a standard part of the Class C/D application process
- A valid ISO 13485 certificate and, for imports, a free sale certificate are mandatory — check validity and procurement timelines early
- The license is valid indefinitely, but a retention fee must be paid every 5 years
- Post-grant, license holders must maintain GMP compliance, report adverse events and field safety actions, and update the Device Master File and Plant Master File whenever material changes occur
Your Next Step
The CDSCO license for an implantable medical device is the regulatory gateway that determines whether your product can legally reach the patients who need it — and, because these devices remain inside the body, it is also CDSCO's primary mechanism for ensuring that only companies with genuinely robust design, manufacturing, and quality systems are permitted to bring implants to the Indian market. Applicants who treat the Device Master File and Plant Master File as living technical records — accurate, current, and audit-ready from day one — move through CDSCO's review and inspection process with far fewer surprises than those who prepare documentation only to satisfy a submission checklist.
If you are preparing your first implantable device license application, planning an MD15 import application as a foreign manufacturer, or need to resolve queries or audit observations from a previous submission, Rego Services' regulatory team provides end-to-end support — from initial classification confirmation through Device Master File and Plant Master File preparation, SUGAM submission, query response, audit readiness, and post-grant compliance planning.
Speak to a Rego Services regulatory consultant today to map out your implantable medical device licensing pathway and understand what documentation you need to prepare before your SUGAM submission.